Lumida
/TERN
⌘K
Terns Pharmaceuticals Inc

Terns Pharmaceuticals Inc

TERN
$52.95USD+0.04%+0.02 today

MARKET CAP

6.1B

P/E (TTM)

FWD P/E

DAY RANGE

$53 – $53

52W RANGE

$3
$53

AI Summary

Stalk
StalkMedium

TERN is in a clear Stage 2 advancing regime with a dominant higher highs & higher lows pattern and rising EMAs, but price is currently extended above structure and extreme overbought—medium-term bias remains bullish, yet short-term timing is neutral; wait for a pullback into the rising EMA zone before initiating longs.

  • Merck’s $6.7B all-cash deal at $53.00/share reflects strong premium
  • Deal closed May 5, 2026, minimizing acquisition uncertainty
  • Post-acquisition delisting halts TERN trading, stripping liquidity
Full analysis →
Sales, Adj.
Gross Profit, Adj.
EBITDA, Adj.
EBIT
Net Income